Fingerprint
Dive into the research topics of 'AUGMENT: A Phase III study of lenalidomide plus rituximab versus placebo plus rituximab in relapsed or refractory indolent lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically